Seasonal Affective Disorder
📧 Sign up to get email alerts when something new happens for Seasonal Affective Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-12-10FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
The FDA approved Upsher-Smith Laboratories' supplemental application for bupropion hydrochloride, updating the product labeling.
-
FDA label_change · 2019-11-05FDA Approved: WELLBUTRIN SR — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for Wellbutrin SR, updating the labeling for the bupropion extended-release formulation following Gl…
-
FDA approval · 2019-11-05FDA Approved: WELLBUTRIN XL — Supplemental Application (Bausch Health US LLC)
The FDA approved a supplemental application for WELLBUTRIN XL (bupropion hydrochloride) submitted by Bausch Health US LLC under NDA021515.
-
FDA approval · 2019-09-05FDA Approved: BUPROPION HYDROCHLORIDE XL — Original Application (Oryza pharmaceuticals Inc.)
FDA approved a generic version of bupropion hydrochloride extended-release (XL) from Oryza Pharmaceuticals Inc. under an original applicatio…
-
CLINICAL_TRIALS trial_result · 2019-01-30Clinical Trial Update: 30-Minute Light Exposure for the Treatment of Seasonal Affective Disorder [NA]
Clinical trial update on 30-minute light exposure as a treatment for Seasonal Affective Disorder. The study completed and results were poste…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2019-01-28FDA Approved: BUPROPION HYDROCHLORIDE — Original Application (Rising Pharma Holdings, Inc.)
FDA approved an original application for bupropion hydrochloride as a generic drug. The approval was issued to Rising Pharma Holdings, Inc.
-
FDA approval · 2019-01-24FDA Approved: BUPROPION HYDROCHLORIDE XL — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals, Inc.'s generic Bupropion Hydrochloride XL as an extended-release antidepressant under an ANDA supplement…
-
FDA approval · 2018-10-31FDA Approved: BUPROPION HYDROCHLORIDE — Original Application (Accord Healthcare Inc.)
FDA approved Accord Healthcare's original application for a generic bupropion hydrochloride product. The approval supports use for major dep…
-
FDA approval · 2018-10-16FDA Approved: BUPROPION HYDROCHLORIDE SR — Original Application (Slate Run Pharmaceuticals, LLC)
FDA approves the original generic application for Bupropion Hydrochloride SR, enabling Slate Run Pharmaceuticals to market a generic sustain…
-
FDA approval · 2018-07-23FDA Approved: BUPROPION — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Bupropion from Zydus Pharmaceuticals USA Inc., indicating an approved update to an existing Bupr…
-
FDA approval · 2018-06-08FDA Approved: BUPROPION HYDROCHLORIDE — Original Application (Alembic Pharmaceuticals Limited)
FDA approved Alembic Pharmaceuticals Limited's Bupropion hydrochloride as a generic drug under an Original Application (ANDA). The product i…
-
CLINICAL_TRIALS trial_result · 2018-05-09Clinical Trial Update: Influence of Light Exposure on Cerebral MAO-A in Seasonal Affective Disorder and Healthy Controls Measured by PET [NA]
This completed trial assessed the influence of light exposure on cerebral MAO-A levels in Seasonal Affective Disorder patients and healthy c…
-
FDA approval · 2017-12-14FDA Approved: BUPROPION HYDROCHLORIDE SR — Supplemental Application (Solco Healthcare US LLC)
FDA approved a supplemental application for a generic formulation of bupropion hydrochloride sustained-release (SR) by Solco Healthcare US L…
-
FDA approval · 2017-11-03FDA Approved: BUPROPION HYDROCHLORIDE SR — Supplemental Application (Dr. Reddys Laboratories Inc.)
FDA approved a supplemental application for Bupropion Hydrochloride SR from Dr. Reddy's Laboratories Inc., enabling the generic product's ma…
-
FDA approval · 2017-11-03FDA Approved: BUPROPION HYDROCHLORIDE (XL) — Original Application (Upsher-Smith Laboratories, LLC)
FDA approved a new original application for Bupropion Hydrochloride Extended-Release (XL) by Upsher-Smith Laboratories, LLC, enabling generi…
-
FDA approval · 2017-09-26FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for a generic Bupropion hydrochloride product from Amneal Pharmaceuticals of New York LLC.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Clinical Trial of Propranolol for Seasonal Affective Disorder [Phase 2]
Propranolol was studied in a Phase 2 trial for seasonal affective disorder, and the document notes that the trial status is COMPLETED. It al…
-
FDA approval · 2017-06-30FDA Approved: BUPROPION HYDROCHLORIDE SR — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for Bupropion Hydrochloride SR from Actavis Pharma, Inc., granting approval of a generic sustain…
-
FDA approval · 2017-06-30FDA Approved: BUPROPION HYDROCHLORIDE (SR) — Supplemental Application (ScieGen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Bupropion hydrochloride sustained-release from ScieGen Pharmaceuticals, Inc. (ANDA 206122). …
-
FDA approval · 2017-06-30FDA Approved: BUPROPION HYDROCHLORIDE XL — Original Application (Epic Pharma, LLC)
FDA approves Epic Pharma's generic bupropion hydrochloride extended-release tablets (Bupropion HCl XL) under an Original Application, adding…
-
FDA approval · 2017-06-12FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Bupropion hydrochloride from Aurobindo Pharma Limited, granting generic drug status for this API…
-
FDA approval · 2017-05-04FDA Approved: APLENZIN — Supplemental Application (Bausch Health US, LLC)
FDA approved a supplemental NDA for APLENZIN (bupropion hydrobromide) from Bausch Health US, LLC. The approval involves a supplemental submi…
-
FDA approval · 2017-04-17FDA Approved: BUPROPION HYDROCHLORIDE SR — Supplemental Application (Dr. Reddys Laboratories Inc.)
The FDA approved a supplemental application for Bupropion hydrochloride SR from Dr. Reddy's Laboratories Inc., enabling marketing of this ge…
-
FDA approval · 2017-04-12FDA Approved: BUPROPION HYDROCHLORIDE (XL) — Original Application (ScieGen Pharmaceuticals,Inc.)
FDA approved ScieGen Pharmaceuticals' generic bupropion hydrochloride extended-release (XL) for the same indications as the reference produc…
-
CLINICAL_TRIALS trial_result · 2017-01-23Clinical Trial Update: Prevention of Seasonal Affective Disorder [Phase 3]
A Phase 3 clinical trial investigating prevention of Seasonal Affective Disorder has completed.